Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Koen van Besien, MD, PhD

Koen van Besien, MD, PhD

  • Director, Wesley Center for Immunotherapy, UH Seidman Cancer Center
  • Division Chief, Hematology and Cellular Therapy, UH Cleveland Medical Center
  • Clinical Professor, CWRU School of Medicine
  • Don C. Dangler Chair in Stem Cell Research, UH Seidman Cancer Center
  • Specialty: Hematology and Oncology
  • Location:
    UH Seidman Cancer Center
    11100 Euclid Ave
    Cleveland, OH 44106

Biography: Koen van Besien, MD, PhD

Expertise

  • CAR T Cell Therapy
  • Leukemia
  • Lymphoma
  • Stem Cell Transplant

Certifications & Memberships

  • Hematology - American Board of Internal Medicine
  • Medical Oncology - American Board of Internal Medicine

Education

Fellowship | Hematology/Oncology
Hematology/Oncology - Indiana University Hospital (1987 - 1990)

Other Education
Maastricht University (2006)

Medical Education
Katholieke Universiteit Leuven, Faculteit Der Geneeskunde (1984)

Featured Videos

Watch to find out more about this University Hospitals provider.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Koen van Besien did not disclose any Outside Relationships with Industry.